Roche Products Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
211 result(s) found, displaying 11 to 20
-
Australian Public Assessment Report (AusPAR)Polivy (polatuzumab vedotin) was approved for the treatment of adult patients with previously untreated diffuse large B-cell lymphoma.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Sep-2024Prescription medicine evaluationActive ingredient: glofitamab.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd